| RASSF10 may encode a novel epigenetically inactivated candidate tumor suppressor gene in thyroid carcinogenesis. | thyroid, |
| This is the first report demonstrating that RASSF10 can act as a tumor suppressor gene and is frequently methylated in gliomas | glioma, |
| the results of this study provide insight into the role of RASSF10 as a novel functional tumor suppressor in gastric cancer through inhibition of the Wnt/beta-catenin signaling pathway. | gastric, |
| RASSF10 was frequently methylated in human esophageal squamous cell carcinoma and expression of RASSF10 was regulated by promoter region hypermethylation. RASSF10 may serve as a tumor suppressor of esophageal cancer | esophageal, |
| RASSF10 functions as a tumor suppressor by cooperating with GSTP1 to deregulate JNK/c-Jun/AP-1 pathway in gastric cancer | gastric, |
| RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma | liver, |
| DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia | leukemia, |
| Like a tumor suppressor gene, RASSF10 can inhibit the proliferation, invasion, and migration of hepatocellular carcinoma cells | liver, |
| Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia | leukemia, |
| Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma | None |
| RASSF10 Is a TGF?-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer | None |